Literature DB >> 7519157

mRNAs encoding muscarinic and substance P receptors in cultured sympathetic neurons are differentially regulated by LIF or CNTF.

W H Ludlam1, Z Zang, K E McCarson, J E Krause, D C Spray, J A Kessler.   

Abstract

Leukemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) have previously been shown to regulate neuronal choice of neurotransmitter. In this present study, these factors were shown to specifically and differentially regulate levels of both muscarinic (subtypes m1, m2, m3, m4, and m5) and substance P receptor (SPR) mRNAs in sympathetic neurons of the rat superior cervical ganglion (SCG) using solution hybridization/RNase protection analysis. In vivo, neonatal rat SCG expressed predominantly m2 (10.31 +/- 0.43 pg mRNA/micrograms total RNA) and some m1 (1.54 +/- 0.84 pg/microgram) muscarinic receptor mRNA, which increased developmentally to adult levels (m2 mRNA levels being 60% higher than those in neonates). By contrast, m3, m4, and m5 subtype mRNAs were much less abundant at all time points measured. A similar developmental regulation was found in dissociated SCG neurons in vitro. After 16 days in culture, m2 mRNA increased 334% to 15.76 +/- 0.68 pg/microgram, while m1 mRNA changed little (2.03 +/- 1.00 pg/microgram). However, LIF or CNTF treatment (5 ng/ml, 14 days) in sister cultures completely blocked this developmental increase. Further, LIF treatment blocked the normal muscarinic receptor-mediated increase in intracellular calcium (fura-2 imaging), indicating a functional change in receptor phenotype. By contrast, levels of SPR mRNA, which were low in untreated cultures (0.037 +/- 0.025 pg SPR mRNA/microgram total RNA), were elevated by LIF or CNTF treatment, to 0.866 +/- 0.034 pg/microgram and 0.662 +/- 0.148 pg/microgram, respectively. These observations indicate that muscarinic and SPR receptor expression are differentially regulated by the same factors in SCG neurons and that neuronal choice of receptor phenotype may be, at least in part, specifically regulated by cytokines/growth factors in the cellular milieu.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519157     DOI: 10.1006/dbio.1994.1221

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  7 in total

1.  Distinct mixtures of muscarinic receptor subtypes mediate inhibition of noradrenaline release in different mouse peripheral tissues, as studied with receptor knockout mice.

Authors:  Anne-Ulrike Trendelenburg; Angelika Meyer; Jürgen Wess; Klaus Starke
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

2.  A sensitive RNase protection assay using 33P labeled antisense riboprobes.

Authors:  C Meisinger; C Grothe
Journal:  Mol Biotechnol       Date:  1996-06       Impact factor: 2.695

3.  Isolation and characterization of the chicken m2 acetylcholine receptor promoter region: induction of gene transcription by leukemia inhibitory factor and ciliary neurotrophic factor.

Authors:  M L Rosoff; J Wei; N M Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Leukaemia inhibitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants.

Authors:  D A Knight; A C D'Aprile; L J Spalding; R G Goldie; P J Thompson
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation.

Authors:  Cheil Moon; Joo-Yeon Yoo; Valéry Matarazzo; Young Kwan Sung; Esther J Kim; Gabriele V Ronnett
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

6.  gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury.

Authors:  Richard E Zigmond
Journal:  Front Mol Neurosci       Date:  2012-01-20       Impact factor: 5.639

7.  LIF upregulates expression of NK-1R in NHBE cells.

Authors:  Cheng-Ping Hu; Jun-Tao Feng; Yu-Ling Tang; Jin-Qi Zhu; Min-Juan Lin; Ming-En Yu
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.